Working… Menu

HIV Drug Switch Followed by HCV Therapy in HIV-HCV Co-Infection (CTN289)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02660905
Recruitment Status : Unknown
Verified April 2017 by Ottawa Hospital Research Institute.
Recruitment status was:  Active, not recruiting
First Posted : January 21, 2016
Last Update Posted : April 26, 2017
Gilead Sciences
CIHR Canadian HIV Trials Network
Information provided by (Responsible Party):
Ottawa Hospital Research Institute

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : November 2017
Estimated Study Completion Date : December 2017